title: [Efficacy and compliance of specific immunotherapy in allergic rhinitis].
abstract: To evaluate the efficacy, safety and compliance of specific immunotherapy in allergic rhinitis.
  
  
  
  Two hundred and eighty cases with allergic rhinitis were undertaken immunotherapy, and then were observed its symptoms, signs and treatment by graded score.
  
  
  
  Total effective rate was 86.8%, 70.4%, 62.5% at 16 week, 6 months and 1 year after treatment. Of 280 patients treated, 74 patients stopped treatment after one year, compliance rate was 73.6%.
  
  
  
  Specific immunotherapy is a safe and effective treatment methods for allergic rhinitis and worthy of attention and promotion, while strengthening the health education is needed to improve treatment compliance of patients.
authors.affiliation: Department of Otorhinolaryngology, Foshan Traditional Chinese Medical Hospital, Foshan, 528000, China. YE95226@126.com
authors.forename: Li
authors.initials: L
authors.lastname: Kuang
authors.forename: Huiling
authors.initials: HL
authors.lastname: Feng
authors.forename: Bingbin
authors.initials: BB
authors.lastname: Xie
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003888:Desensitization, Immunologic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*; D016896:Treatment Outcome; D055815:Young Adult